Physician profile
Michael A Wilson
NPI 1871539973
$6,008.60
in general payments reported to CMS, 2019-2025
18 companies · $22.31 in 2025
The $22.31 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $506 · 2020: $312 · 2021: $1,132 · 2022: $3,598 · 2023: $361 · 2024: $78.79 · 2025: $22.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,650.87 | 2019-2024 | Diamondback Peripheral, Perclose Prostyle |
| Medicure Pharma INC. | $1,000.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $429.92 | 2020-2021 | |
| Boston Scientific Corporation | $201.88 | 2019-2022 | |
| Heartflow, INC. | $145.22 | 2019 | |
| Abiomed | $117.24 | 2019-2022 | |
| Shockwave Medical, INC | $108.97 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $107.45 | 2019-2022 | |
| Inari Medical, INC. | $55.05 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic Vascular, INC. | $38.51 | 2019 | |
| Biotronik INC. | $32.84 | 2022 | |
| Cardiovascular Systems INC. | $27.18 | 2023 | Diamondback Coronary |
| Becton, Dickinson and Company | $22.31 | 2025 | Lutonix Drug Coated Balloon |
| Stryker Corporation | $15.31 | 2023 | Scopis Ent |
| Astrazeneca Pharmaceuticals LP | $14.32 | 2023 | Farxiga |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $14.22 | 2023 | Benchmark |
| Medtronic, INC. | $13.72 | 2023 | Onyx Frontier |
| Edwards Lifesciences Corporation | $13.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.